BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32244375)

  • 21. Preclinical evaluation of a paclitaxel-incorporated nanoparticle-coated balloon in rabbit and porcine models.
    Yamamoto E; Watanabe S; Bao B; Watanabe H; Nakatsuma K; Izuhara M; Ono K; Nakazawa G; Kimura T; Saito N
    Cardiovasc Revasc Med; 2018 Jun; 19(4):433-437. PubMed ID: 29174499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel-coated versus plain old balloon angioplasty for the treatment of infrainguinal arterial disease in diabetic patients: the Belgian diabetic IN.PACT Trial.
    Debing E; Aerden D; Vanhulle A; Gallala S; von Kemp K;
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):528-534. PubMed ID: 27727202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients.
    Radke PW; Joner M; Joost A; Byrne RA; Hartwig S; Bayer G; Steigerwald K; Wittchow E
    EuroIntervention; 2011 Oct; 7(6):730-7. PubMed ID: 21986331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries.
    Torii S; Yahagi K; Mori H; Harari E; Romero ME; Kolodgie FD; Young B; Ragheb A; Virmani R; Finn AV
    J Vasc Interv Radiol; 2018 Jul; 29(7):1041-1049.e3. PubMed ID: 29754850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel, vessel anatomy adjusting drug-coated balloon-Preclinical evaluation in peripheral porcine arteries.
    Bienek S; Kusmierczuk M; Mittag A; Bettink S; Scheller B
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):319-328. PubMed ID: 31696642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.
    Buszman PP; Milewski K; Zurakowski A; Pajak J; Jelonek M; Gasior P; Peppas A; Tellez A; Granada JF; Buszman PE
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):325-33. PubMed ID: 23703720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial.
    Scheinert D; Schulte KL; Zeller T; Lammer J; Tepe G
    J Endovasc Ther; 2015 Feb; 22(1):14-21. PubMed ID: 25775674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How does a drug-coated balloon work? Overview of coating techniques and their impact.
    Speck U; Stolzenburg N; Peters D; Scheller B
    J Cardiovasc Surg (Torino); 2016 Feb; 57(1):3-11. PubMed ID: 26771720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine.
    Kolodgie FD; Pacheco E; Yahagi K; Mori H; Ladich E; Virmani R
    J Vasc Interv Radiol; 2016 Nov; 27(11):1676-1685.e2. PubMed ID: 27641674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Patency of Long-Segment Femoropopliteal Artery Lesions in Patients with Peripheral Arterial Occlusive Disease Treated with Paclitaxel-Eluting Technology.
    Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
    Ann Vasc Surg; 2020 Jul; 66():595-600. PubMed ID: 31863948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stellarex drug-coated balloon: a technology evaluation.
    Nerla R; Castriota F; Cremonesi A; Micari A
    Expert Opin Drug Deliv; 2020 Sep; 17(9):1181-1188. PubMed ID: 32615811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial.
    Schneider PA; Laird JR; Tepe G; Brodmann M; Zeller T; Scheinert D; Metzger C; Micari A; Sachar R; Jaff MR; Wang H; Hasenbank MS; Krishnan P;
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005891. PubMed ID: 29326153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
    Mehrotra S; Paramasivam G; Mishra S
    Curr Cardiol Rep; 2017 Feb; 19(2):10. PubMed ID: 28185166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon.
    Schneider PA; Laird JR; Doros G; Gao Q; Ansel G; Brodmann M; Micari A; Shishehbor MH; Tepe G; Zeller T
    J Am Coll Cardiol; 2019 May; 73(20):2550-2563. PubMed ID: 30690141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions: 24-Month Results of AcoArt I.
    Xu Y; Jia X; Zhang J; Zhuang B; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2347-2353. PubMed ID: 30448170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic coating morphology modulates acute drug transfer in drug-coated balloon therapy.
    Chang GH; Azar DA; Lyle C; Chitalia VC; Shazly T; Kolachalama VB
    Sci Rep; 2019 May; 9(1):6839. PubMed ID: 31048704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
    Bausback Y; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
    J Endovasc Ther; 2017 Aug; 24(4):459-467. PubMed ID: 28558502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound controlled paclitaxel releasing system-A novel method for improving the availability of coronary artery drug coated balloon.
    Song C; Zhou C; Zhang J; Feng X; Cui X; Zhang F; Ma J; Toft ES; Ge J; Zhang H
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E119-E128. PubMed ID: 31659805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrophilic Coating Microstructure Mediates Acute Drug Transfer in Drug-Coated Balloon Therapy.
    Shazly T; Eberth JF; Kostelnik CJ; Uline MJ; Chitalia VC; Spinale FG; Alshareef A; Kolachalama VB
    ACS Appl Bio Mater; 2024 May; 7(5):3041-3049. PubMed ID: 38661721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.